Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00803660 |
Multi-centre survey of type 2 diabetic patients who are currently on anti-hypertensive treatment. Data collection for each patient will take place at one visit. To observe the proportion of diabetic patients on antihypertensive treatment reaching the BP<130/80 mmHg. To observe the proportion of diabetic patients on antihypertensive treatment reaching the BP<130/80 mmHg by treatment groups. To observe the proportion of patients achieving a therapeutic glycemic response defined as HbA1c=<7%. To observe the proportion of patients achieving fasting plasma glucose<110 mg%. To identify factors for not achieving BP<130/80 mmHg. To describe percentage of patients with positive proteinuria (including microalbuminuria) by treatment groups .
Condition |
---|
Hypertension Type 2 Diabetes |
Study Type: | Observational |
Study Design: | Cross-Sectional |
Official Title: | In Practice Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes. |
Estimated Enrollment: | 1060 |
Study Start Date: | November 2008 |
Estimated Study Completion Date: | June 2009 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
type 2 diabetic patients who are currently using antihypertensive treatment for at least 3 months, with same regimen for a minimum of 4 weeks prior to the survey
Inclusion Criteria:
Exclusion Criteria:
Contact: AstraZeneca Vietnam Clinical Study Information | (84.8) 3 8278088 | viettuan.vo@astrazeneca.com |
Vietnam | |
Research Site | Not yet recruiting |
Ho Chi Minh, Vietnam | |
Research Site | Not yet recruiting |
Hai Phong, Vietnam | |
Research Site | Not yet recruiting |
An Giang, Vietnam | |
Research Site | Not yet recruiting |
Bac Lieu, Vietnam | |
Research Site | Not yet recruiting |
Hanoi, Vietnam | |
Research Site | Not yet recruiting |
Can Tho, Vietnam | |
Research Site | Not yet recruiting |
Da Nang, Vietnam | |
Research Site | Not yet recruiting |
Dong Thap, Vietnam | |
Research Site | Not yet recruiting |
Ca Mau, Vietnam | |
Research Site | Not yet recruiting |
Kien Giang, Vietnam | |
Research Site | Not yet recruiting |
Nam Dinh, Vietnam | |
Research Site | Not yet recruiting |
Thai Binh, Vietnam | |
Research Site | Not yet recruiting |
Tien Giang, Vietnam | |
Vietnam, Binh Dinh | |
Research Site | Not yet recruiting |
Qui Nhon, Binh Dinh, Vietnam | |
Vietnam, Dak Lak | |
Research Site | Not yet recruiting |
Buon Me Thuoc, Dak Lak, Vietnam | |
Vietnam, Dong Nai | |
Research Site | Not yet recruiting |
Bien Hoa, Dong Nai, Vietnam | |
Research Site | Not yet recruiting |
Thong Nhat, Dong Nai, Vietnam | |
Vietnam, Khanh Hoa | |
Research Site | Recruiting |
Nha Trang, Khanh Hoa, Vietnam | |
Vietnam, Thua Thien | |
Research Site | Recruiting |
Hue, Thua Thien, Vietnam |
Principal Investigator: | Dang Van Phuoc, PhD. | University of Medicine and Pharmacy of HCMC |
Principal Investigator: | Pham Nguyen Vinh, PhD. | Tam Duc Heart Hospital |
Principal Investigator: | Pham Gia Khai, PhD. | Vietnam Heart Association |
Principal Investigator: | Nguyen Thy Khue, PhD | Endocrinology and Diabetes Association of HCMC |
Responsible Party: | AstraZeneca Pharmaceuticals ( Vo Viet Tuan ) |
Study ID Numbers: | NIS-CVN-DUM-2008/1 |
Study First Received: | December 3, 2008 |
Last Updated: | December 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00803660 History of Changes |
Health Authority: | Vietnam: Ministry of Health |
hypertension BP diabetes |
anti-hypertensive treatment ACE-I ARB |
Metabolic Diseases Diabetes Mellitus, Type 2 Vascular Diseases Diabetes Mellitus Angiotensin-Converting Enzyme Inhibitors Endocrine System Diseases |
Endocrinopathy Antihypertensive Agents Glucose Metabolism Disorders Metabolic Disorder Hypertension |
Metabolic Diseases Diabetes Mellitus, Type 2 Vascular Diseases Diabetes Mellitus |
Endocrine System Diseases Cardiovascular Diseases Glucose Metabolism Disorders Hypertension |